A Review on Patients with Mitral Stenosis: Pathophysiology, Investigations, and Treatment

Main Article Content

Omar Elsaka
Moneer Ayman Noureldean
Mohamed Adel Gamil
Mostafa Tarek Ghazali
Ashraf Hamada Abd Al-Razik
Dalia Hisham

Abstract

Background: Mitral stenosis (MS) is a common valvular condition marked by a narrowing of the mitral valve orifice and a decrease in the area of the mitral valve (MVA). While rheumatic MS (RMS) is common among young people in underdeveloped nations, degenerative MS (DMS) is more common among the elderly in industrialized countries, and its incidence is rising. DMS is frequently the result of mitral annular calcification that has progressed to a late stage (MAC). Because of the modifications in the atrial and valvular structures, as well as the presence of other comorbidities in this aging population, accurate measurement of MVA in patients with MAC is difficult. We will compare and contrast the epidemiology, etiology, pathophysiology, diagnostic assessment, and therapy of DMS with RMS. The most up-to-date therapeutic techniques will be reviewed, including medicinal, surgical, and transcatheter valvular procedures.

Conclusion: The goal of this review article is to go over the causes of mitral stenosis, the typical exam of a patient with mitral stenosis, the treatment for mitral stenosis, and the modalities for improving care coordination among interprofessional team members to improve outcomes for patients with mitral stenosis.

Keywords:
Mitral valve, pathophysiology, degenerative mitral stenosis, echocardiography, mitral annular calcification, valvular disease

Article Details

How to Cite
Elsaka, O., Noureldean, M. A., Gamil, M. A., Ghazali, M. T., Al-Razik, A. H. A., & Hisham, D. (2022). A Review on Patients with Mitral Stenosis: Pathophysiology, Investigations, and Treatment. Asian Research Journal of Current Science, 4(1), 30-40. Retrieved from https://globalpresshub.com/index.php/ARJOCS/article/view/1401
Section
Review Article

References

Baddour LM, Wilson WR, Bayer AS, et al, for the American Heart Association Committee of Rheumatic Fever, Endocarditis, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15): 1435-86.

Baumgartner H, Falk V, Bax JJ, et al. for the ESC Scientific Document Group. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-91.

Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: A scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation. 2009;119(11):1541-51.

Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128.

Nishimura RA, Otto CM, Bonow RO, et al, for the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57-185.

Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(25):e1159-95.

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71.

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72-e227.

Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012; 33(19):2451-96.

Wann LS, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2011;57(11):1330-7.

Antonini-Canterin F, Moura LM, Enache R, et al. Effect of hydroxymethylglutaryl coenzyme-a reductase inhibitors on the long-term progression of rheumatic mitral valve disease. Circulation. 2010;121(19):2130-6.

Bruce CJ, Nishimura RA. Newer advances in the diagnosis and treatment of mitral stenosis. Curr Probl Cardiol. 1998;23(3):125-92.

Chan V, Elmistekawy E, Ruel M, Hynes M, Mesana TG. How does mitral valve repair fail in patients with prolapse?-Insights from longitudinal echocardiographic follow-up. Ann Thorac Surg. 2016;102(5):1459-65.

El Sabbagh A, Eleid MF, Foley TA, et al. Direct transatrial implantation of balloon-expandable valve for mitral stenosis with severe annular calcifications: Early experience and lessons learned. Eur J Cardiothorac Surg. 2018;53(1):162-9.

El-Dosouky II. Match and mismatch between opening area and resistance in mild and moderate rheumatic mitral stenosis. Echocardiography. 2016;33(12): 1801-4.

Feldman T. Rheumatic mitral stenosis. Curr Treat Options Cardiovasc Med. 2000 Apr. 2(2):93-104.

Goldstone AB, Woo YJ. Is minimally invasive thoracoscopic surgery the new benchmark for treating mitral valve disease?. Ann Cardiothorac Surg. 2016; 5(6):567-72.

Henri C, Pierard LA, Lancellotti P, Mongeon FP, Pibarot P, Basmadjian AJ. Exercise testing and stress imaging in valvular heart disease. Can J Cardiol. 2014;30(9):1012-26.

Holmes DR Jr, Mack MJ. Transcatheter valve therapy a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58(4):445-55.

Inci S, Nar G, Erol MK, et al. The effects of successful percutaneous mitral balloon valvuloplasty on acute and intermediate term aortic stiffness. Echocardiography. 2015 ;32(5):813-8.

Iwataki M, Takeuchi M, Otani K, et al. Calcific extension towards the mitral valve causes non-rheumatic mitral stenosis in degenerative aortic stenosis: real-time 3D transoesophageal echocardiography study. Open Heart. 2014;1(1):e000136.

Kawamoto N, Fujita T, Fukushima S, et al. Late onset of atrial fibrillation in patients undergoing mitral valve repair for type II dysfunction. J Cardiol. 2018;71(4):346-51.

Mahmoud Elsayed HM, Hassan M, et al. A novel method to measure mitral valve area in patients with rheumatic mitral stenosis using three-dimensional transesophageal echocardiography: Feasibility and validation. Echocardiography. 2018;35(3):368-74.

Nikdoust F, Sadeghian H, Lotfi-Tokaldany M. Regional quantification of left atrial early diastolic strain in two groups of patients with mitral stenosis: Normal sinus rhythm vs atrial fibrillation. Echocardiography. 2016;33(12):1818-22.

Payvandi LA, Rigolin VH. Calcific mitral stenosis. Cardiol Clin. 2013;31(2):193-202.

Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol. 2010;55(22):2413-26.

Saggu DK, Narain VS, Dwivedi SK, et al. Effect of ivabradine on heart rate and duration of exercise in patients with mild-to-moderate mitral stenosis: A randomized comparison with metoprolol. J Cardiovasc Pharmacol. 2015;65(6):552-4.

Schlosshan D, Aggarwal G, Mathur G, Allan R, Cranney G. Real-time 3D transesophageal echocardiography for the evaluation of rheumatic mitral stenosis. JACC Cardiovasc Imaging. 2011;4(6):580-8.

Wunderlich NC, Beigel R, Siegel RJ. Management of mitral stenosis using 2D and 3D echo-Doppler imaging. JACC Cardiovasc Imaging. 2013;6(11):1191- 205.

Most read articles by the same author(s)